Literature DB >> 22499029

Reducing death from melanoma and standards of evidence.

Martin A Weinstock.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22499029     DOI： 10.1038/jid.2012.57

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  5 in total

1.  Notch1 Autoactivation via Transcriptional Regulation of Furin, Which Sustains Notch1 Signaling by Processing Notch1-Activating Proteases ADAM10 and Membrane Type 1 Matrix Metalloproteinase.

Authors:  Hong Qiu; Xiaoying Tang; Jun Ma; Khvaramze Shaverdashvili; Keman Zhang; Barbara Bedogni
Journal:  Mol Cell Biol       Date:  2015-08-17       Impact factor: 4.272

2.  Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General Population.

Authors:  Georgina L Fenton; Amelia K Smit; Lucinda Freeman; Caro Badcock; Kate Dunlop; Phyllis N Butow; Judy Kirk; Anne E Cust
Journal:  J Genet Couns       Date:  2017-12-03       Impact factor: 2.537

3.  Advancing Survivors' Knowledge (ASK) about skin cancer study: study protocol for a randomized controlled trial.

Authors:  Casey L Daniel; Gregory T Armstrong; Robyn R Keske; Jessica A Davine; Aaron J McDonald; Kim M Sprunck-Harrild; Catherine Coleman; Sebastien J Haneuse; Ann C Mertens; Karen M Emmons; Ashfaq A Marghoob; Elena B Elkin; Stephen W Dusza; Leslie L Robison; Alan C Geller
Journal:  Trials       Date:  2015-03-24       Impact factor: 2.279

4.  The Melanoma Genomics Managing Your Risk Study randomised controlled trial: statistical analysis plan.

Authors:  Serigne N Lo; Amelia K Smit; David Espinoza; Anne E Cust
Journal:  Trials       Date:  2020-06-30       Impact factor: 2.279

5.  Public preferences for communicating personal genomic risk information: a focus group study.

Authors:  Amelia K Smit; Louise A Keogh; Jolyn Hersch; Ainsley J Newson; Phyllis Butow; Gabrielle Williams; Anne E Cust
Journal:  Health Expect       Date:  2015-09-01       Impact factor: 3.377
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.